Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
In-situ forming gel
In-situ forming gel comprised of low molecular weight poly (ε-caprolactone) (PCL) and biocompatible solvents. The solvent in the polymer solution dissipates post-injection, leaving behind a biodegradable gel depot that slowly releases levonorgestrel.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Potential Multi-Purpose Technology (MPT):
Began discovery in:
Feasibility studies of injectable in situ gel systems with low initial burst release followed by constant release profiles, in vitro.
KYDES Pharmaceuticals website
Download Product Report